EVMN Evommune, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
12:14
Aug 26
Aug 26
News wire reports multiple price target cuts across a broad set of stocks including DKS, INTU.
News wire reports multiple price target cuts across a broad set of stocks including DKS, INTU, and SYRE, alongside new coverage initiations and resumptions from various analysts.
12:52
Aug 17
Aug 17
Reports most closed positions across funds
"Reports most closed positions across specialist funds in Q2 2026 excluding M&A take-outs, no directional view."
MED
11:57
Aug 17
Aug 17
Reports most closed positions by specialist funds
Reports the most closed positions by specialist funds in Q2 2026, excluding M&A takeouts.
MED
13:52
Jun 29
Jun 29
Buy EVMN on the dip following a drug failure, as the overhang clears and market attention can.
Buy EVMN on the dip following a drug failure, as the overhang clears and market attention can now re-rate the IL-18 program, a potentially differentiated asset in the autoimmune space.
HIGH
About EVMN Analyst Coverage
Buzzberg tracks EVMN (Evommune, Inc.) across 3 sources. 1 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (25%). 4 total trade ideas tracked. Latest voices: DeItaone, seedy19tron, Martin Shkreli.